
Alvotech prices $152M share offering in US and Europe to fund biotech drug development.
Alvotech announced pricing and allocation of a $152 million public share offering in the US and a concurrent private placement in Europe at $3.75 per share. The company expects total proceeds up to $165 million if underwriters exercise their full opt...

